Hempalta Corp. (CVE:HEMP – Get Free Report) Director Darren Hartley Bondar sold 453,000 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of C$0.06, for a total transaction of C$26,274.00.
Darren Hartley Bondar also recently made the following trade(s):
- On Wednesday, January 8th, Darren Hartley Bondar purchased 50,000 shares of Hempalta stock. The shares were acquired at an average price of C$0.06 per share, with a total value of C$3,000.00.
- On Monday, December 30th, Darren Hartley Bondar acquired 50,000 shares of Hempalta stock. The stock was acquired at an average price of C$0.04 per share, for a total transaction of C$2,000.00.
- On Tuesday, December 24th, Darren Hartley Bondar bought 310,474 shares of Hempalta stock. The shares were acquired at an average price of C$0.05 per share, with a total value of C$14,499.14.
- On Tuesday, November 5th, Darren Hartley Bondar purchased 200,000 shares of Hempalta stock. The stock was acquired at an average price of C$0.04 per share, for a total transaction of C$8,000.00.
- On Monday, October 14th, Darren Hartley Bondar purchased 135,000 shares of Hempalta stock. The shares were acquired at an average cost of C$0.04 per share, with a total value of C$5,400.00.
Hempalta Price Performance
CVE:HEMP opened at C$0.06 on Thursday. The firm’s fifty day moving average price is C$0.04 and its two-hundred day moving average price is C$0.10. The company has a debt-to-equity ratio of 28.72, a current ratio of 3.99 and a quick ratio of 0.88. The company has a market cap of C$5.22 million, a P/E ratio of -0.44 and a beta of -0.10. Hempalta Corp. has a one year low of C$0.04 and a one year high of C$0.30.
About Hempalta
Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products. The company also engages in the hemp carbon credit market.
Further Reading
- Five stocks we like better than Hempalta
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Why AMD Stock Might Already Be This Year’s Best Buy
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for Hempalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempalta and related companies with MarketBeat.com's FREE daily email newsletter.